InvestorsHub Logo

cowtown jay

04/08/22 10:12 AM

#36016 RE: 10nisman #36013

If I was Cameron, I'd be focused on our highest priority.

So I would have Adrian, who has the most recent experience with the FDA validation process, working on the submission of our amended EUA application, as the NIH data becomes available.

But to me, perhaps even more important than an EUA authorization, is the need to produce revenue. So I would be in France, working with Cenexi and Clinigen. We have to turn our inventory into revenue, and I think that is a very doable task that does not require the NIH or the FDA. Besides, I would love to re-visit Paris.